Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1996 1
1999 1
2001 2
2002 2
2003 1
2005 1
2007 2
2008 4
2009 5
2010 3
2011 3
2012 1
2013 1
2014 3
2015 2
2016 2
2017 2
2018 2
2019 2
2020 5
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R. Baumert BG, et al. Among authors: rees j. Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686946 Free PMC article. Clinical Trial.
BACKGROUND: Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting molecular heterogeneity of the disease. ...INTERPRETATION: Overall, there was no significant difference in progression-free survival in patients with low-grade glioma when treated …
BACKGROUND: Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting molecular heterogeneity of the disease. ...INTE …
Seizure outcomes and survival in adult low-grade glioma over 11 years: living longer and better.
Solomons MR, Jaunmuktane Z, Weil RS, El-Hassan T, Brandner S, Rees JH. Solomons MR, et al. Among authors: rees jh. Neurooncol Pract. 2020 Mar;7(2):196-201. doi: 10.1093/nop/npz056. Epub 2019 Nov 21. Neurooncol Pract. 2020. PMID: 32206321 Free PMC article.
BACKGROUND: There has been a trend toward earlier and more aggressive resection for low-grade gliomas (LGGs). This study set out to compare seizure control and survival of adults with LGG seen in the same neuro-oncology clinic over 11 years and to determine whether a chang …
BACKGROUND: There has been a trend toward earlier and more aggressive resection for low-grade gliomas (LGGs). This study set out to c …
Longitudinal structural and perfusion MRI enhanced by machine learning outperforms standalone modalities and radiological expertise in high-grade glioma surveillance.
Siakallis L, Sudre CH, Mulholland P, Fersht N, Rees J, Topff L, Thust S, Jager R, Cardoso MJ, Panovska-Griffiths J, Bisdas S. Siakallis L, et al. Among authors: rees j. Neuroradiology. 2021 Dec;63(12):2047-2056. doi: 10.1007/s00234-021-02719-6. Epub 2021 May 28. Neuroradiology. 2021. PMID: 34047805 Free PMC article.
PURPOSE: Surveillance of patients with high-grade glioma (HGG) and identification of disease progression remain a major challenge in neurooncology. ...
PURPOSE: Surveillance of patients with high-grade glioma (HGG) and identification of disease progression remain a major challenge in …
Quantitative imaging biomarkers in neuro-oncology.
Waldman AD, Jackson A, Price SJ, Clark CA, Booth TC, Auer DP, Tofts PS, Collins DJ, Leach MO, Rees JH; National Cancer Research Institute Brain Tumour Imaging Subgroup. Waldman AD, et al. Among authors: rees jh. Nat Rev Clin Oncol. 2009 Aug;6(8):445-54. doi: 10.1038/nrclinonc.2009.92. Epub 2009 Jun 23. Nat Rev Clin Oncol. 2009. PMID: 19546864 Review.
Low-grade gliomas in adults.
Rees JH. Rees JH. Curr Opin Neurol. 2002 Dec;15(6):657-61. doi: 10.1097/01.wco.0000044760.39452.71. Curr Opin Neurol. 2002. PMID: 12447102 Review.
PURPOSE OF REVIEW: This paper aims to summarize the current thinking about the management of adult supratentorial low-grade gliomas. These are well differentiated primary brain tumours that typically develop in young adults. Their biological behaviour is poorly understood …
PURPOSE OF REVIEW: This paper aims to summarize the current thinking about the management of adult supratentorial low-grade gliomas. …
Diagnosis and treatment in neuro-oncology: an oncological perspective.
Rees JH. Rees JH. Br J Radiol. 2011 Dec;84 Spec No 2(Spec Iss 2):S82-9. doi: 10.1259/bjr/18061999. Br J Radiol. 2011. PMID: 22433832 Free PMC article. Review.
Although brain tumours are rare compared with other malignancies, they are responsible, in many cases, for severe physical and cognitive disability and have a high case fatality rate (13% overall survival at 5 years). Gliomas account for over 60% of primary brain tumours a …
Although brain tumours are rare compared with other malignancies, they are responsible, in many cases, for severe physical and cognitive dis …
The use of temozolomide in recurrent malignant gliomas.
Gaya A, Rees J, Greenstein A, Stebbing J. Gaya A, et al. Among authors: rees j. Cancer Treat Rev. 2002 Apr;28(2):115-20. doi: 10.1053/ctrv.2002.0261. Cancer Treat Rev. 2002. PMID: 12297119 Review.
Gliomas are the most common primary intracerebral tumours and over 60% of these are malignant. Standard treatment in the UK for patients with a good performance status consists of surgery and postoperative radiotherapy, however, recurrence is almost inevitable. Treatment o
Gliomas are the most common primary intracerebral tumours and over 60% of these are malignant. Standard treatment in the UK for patie
42 results